Earnings Release • Apr 28, 2011
Earnings Release
Open in ViewerOpens in native device viewer
CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)
CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)
-- First Quarter GAAP Diluted EPS of \$0.59 vs. \$0.50 in the Prior Year Period -- -- Diluted EPS of \$0.68 Up 26% Year-over-Year and 48% Sequentially, Excluding Merger Expenses & Exit Costs -- -- Launched Interest Rate Futures on NYSE Liffe U.S./New York Portfolio Clearing -- -- Global Leader for IPOs, Over 90% share of Proceeds in U.S., Increasing Momentum for Franchise -- -- Integration Planning for Proposed Merger with Deutsche Boerse On-Track --
2 A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.
NEW YORK – April 28, 2011 – NYSE Euronext (NYX) today reported net income of \$155 million, or \$0.59 per diluted share for the first quarter of 2011, compared to net income of \$130 million, or \$0.50 per diluted share for the first quarter of 2010. Results for the first quarter of 2011 and 2010 include \$21 million and \$13 million, respectively, of pre-tax merger expenses and exit costs. Merger expenses and exit costs in the first quarter of 2011 included \$15 million related to the proposed merger with Deutsche Boerse. Excluding the impact of these items, net income in the first quarter of 2011 was \$177 million, or \$0.68 per diluted share, compared to \$140 million, or \$0.54 per diluted share, in the first quarter of 2010.
"These solid results reflect growing strength and momentum across our businesses and validate our long-term strategy to focus on diversifying and expanding our global footprint as the leading global multi-asset exchange," said Duncan L. Niederauer, CEO, NYSE Euronext. "Our innovative NYSE Liffe U.S. launch of interest rate products is off to a strong start, bolstered by the unique benefits of New York Portfolio Clearing. Our listings franchise continues to expand through transfers from Nasdaq, and we were the global leader in IPOs in the first quarter. Lastly, our technology services pipeline continues to build and will accelerate toward our stated revenue goals for 2011.
"We are confident that our strong standalone growth prospects will be enhanced and accelerated by the proposed merger with Deutsche Boerse, through significant efficiency gains, earnings growth and multiple expansion for our shareholders. I look forward to articulating the power of the proposed combination at our annual stockholder meeting later today in New York."
| % Δ 1Q11 |
% Δ 1Q11 |
||||
|---|---|---|---|---|---|
| (\$ in millions, except EPS) | 1Q11 | 4Q10 | vs. 4Q10 | 1Q10 | vs. 1Q10 |
| Total Revenues2 | \$1,148 | \$1,045 | 10% | \$1,083 | 6 % |
| Total Revenues, Less Transaction-Based Expenses 3 | 679 | 613 | 11% | 645 | 5 % |
| Other Operating Expenses 4 | 415 | 425 | (2%) | 427 | (3%) |
| Operating Income 4 | \$264 | \$188 | 40% | \$218 | 21% |
| Net Income4 | \$177 | \$120 | 48% | \$140 | 26% |
| Diluted Earnings Per Share 4 | \$0.68 | \$0.46 | 48% | \$0.54 | 26% |
| Operating Margin | 39% | 31% | 8 ppts | 34% | 5 ppts |
| EBITDA Margin | 49% | 44% | 5 ppts | 44% | 5 ppts |
1 A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.
2 Includes activity assessment fees.
3 Transaction-based expenses include Section 31 fees, liquidity payments and routing & clearing fees.
4 Excludes merger expenses and exit costs.
Michael S. Geltzeiler, Group Executive Vice President and CFO, NYSE Euronext commented, "Our first quarter results represent a return to the growth trajectory established for NYSE Euronext before the second half of 2010, and underscores the power of the inherent leverage in our model both year-over-year and sequentially. Net revenue growth of 5% yearover-year, accompanied by a 3% decrease in expenses drove a 21% increase in operating income, a 26% increase in diluted earnings per share and incremental margins of over 130%. We are continuing our multi-year cost containment initiative which has reduced our cost base by over \$600 million since the merger with Euronext in 2007, on a constant dollar, constant portfolio basis. Higher EBITDA and lower capital expenditures have translated into strong free cash flow which, supported by an "A" rated balance sheet, creates significant organic growth opportunities and strongly positions us to return capital to shareholders."
Total revenues, less transaction-based expenses, which include Section 31 fees, liquidity payments and routing and clearing fees (net revenue), was \$679 million in the first quarter of 2011, up \$34 million, or 5% compared to the first quarter of 2010 and was up 11% compared to the fourth quarter of 2010. The \$34 million increase in net revenue compared to the first quarter of 2010, which included a \$2 million positive impact from currency fluctuations, was primarily driven by a \$22 million increase in net trading revenues, with increases across all trading venues as well as a \$12 million increase in non-trading revenue driven by increases in market data, listings and technology services fees. The \$66 million, or 11% increase in net revenue compared to the fourth quarter of 2010 was driven by higher net trading revenues across all venues, principally European derivatives and European cash which experienced trading ADV increases of 24% and 29%, respectively.
Other operating expenses, which exclude merger expenses and exit costs, were \$415 million in the first quarter of 2011, down \$12 million, or 3% compared to the first quarter of 2010 and decreased 2% compared to the fourth quarter of 2010. The \$12 million decrease in fixed costs compared to the first quarter of 2010, which included a \$2 million negative impact for foreign currency fluctuations, was primarily driven by an \$11 million decrease in compensation costs and a \$16 million decrease in selling, general and administrative expenses, partially offset by higher professional services fees and depreciation and amortization.
For the full-year 2011, fixed operating expenses are expected to be less than \$1,650 million on a constant dollar, constant portfolio basis, compared to full-year 2010 expenses of \$1,678 million.
Operating income, excluding merger expenses and exit costs, was \$264 million, up \$46 million, or 21% compared to the first quarter of 2010 and increased \$76 million, or 40% compared to the fourth quarter of 2010.
Adjusted EBITDA, which excludes merger expenses and exit costs, was \$334 million, up \$50 million, or 18% compared to the first quarter of 2010 and increased \$66 million, or 25% compared to the fourth quarter of 2010. Adjusted EBITDA margin was 49% in the first quarter of 2011, compared to 44% in the first quarter of 2010.
Non-operating income for the first quarter of 2011 includes the impact of the investment in New York Portfolio Clearing (loss/income from associates) and NYSE Liffe U.S. (net loss/income attributable to non-controlling interest) initiatives.
Both New York Portfolio Clearing and NYSE Liffe U.S. are currently in a loss position, however, the financial results of the two initiatives are expected to improve with the launch of interest rate futures on NYSE Liffe U.S. which are cleared through New York Portfolio Clearing.
The effective tax rate for the first quarter of 2011 was approximately 26%. For the full-year 2011, the effective tax rate is expected to be 26%.
The weighted average diluted shares outstanding in the first quarter of 2011 was 262 million, up from 261 million shares in the first quarter of 2010. For the full-year 2011, the weighted average diluted shares outstanding is expected to be 263 million. With the sale of the former American Stock Exchange headquarters building, approximately 0.3 million shares will be issued in the second quarter of 2011.
At March 31, 2011, total debt of \$2.4 billion was \$83 million below December 31, 2010 levels and consisted of \$2.2 billion in long-term debt and \$0.2 billion in short-term debt. Cash, cash equivalents, investments and other securities (including \$88 million related to Section 31 fees collected from market participants and due to the SEC) was \$0.4 billion and net debt was \$2.0 billion.
The ratio of debt-to-EBITDA in the first quarter of 2011 declined to 1.8 times, the lowest level since the establishment of NYSE Euronext in April 2007, from 2.2 times in the fourth quarter of 2010. The decrease in the debt-to-EBITDA ratio reflects the strong growth in adjusted EBITDA, lower capital expenditures and continued deleveraging relative to the fourth quarter of 2010.
Total capital expenditures in the first quarter of 2011 were \$36 million compared to \$92 million in the first quarter of 2010. For the full-year 2011 total capital expenditures are expected to be less than \$200 million.
Headcount as of March 31, 2011 was 3,028 (including 75 headcount from the closing of APX, Inc. and the creation of NYSE BlueTM), up 2% from December 31, 2010, but down 6% from March 31, 2010.
The Board of Directors declared a cash dividend of \$0.30 per share for the second quarter of 2011. The second quarter 2011 dividend is payable June 30, 2011 to shareholders of record as of the close of business on June 16, 2011. The anticipated ex-date will be June 14, 2011.
Below is a summary of business segment results:
| Derivatives | Cash Trading & Listings | Info. Svcs. & Tech. Solutions | |||||||
|---|---|---|---|---|---|---|---|---|---|
| (\$ in millions) | Net | Operating Adjusted | Net | Operating | Adjusted | Net | Operating | Adjusted | |
| Revenue1 | Income2 | EBITDA2 Revenue1 | Income2 | EBITDA2 Revenue1 | Income2 | EBITDA2 | |||
| 1Q11 | \$236 | \$146 | \$161 | \$328 | \$125 | \$171 | \$116 | \$28 | \$37 |
| 4Q10 | \$188 | \$91 | \$108 | \$310 | \$99 | \$153 | \$114 | \$28 | \$37 |
| 1Q10 | \$224 | \$130 | \$145 | \$312 | \$106 | \$149 | \$110 | \$17 | \$25 |
1 Net revenue defined as total revenue less transaction-based expenses including Section 31 fees, liquidity payments and routing & clearing fees. 2 Excludes merger expenses and exit costs.
Derivatives net revenue of \$236 million in the first quarter of 2011 increased \$12 million, or 5% compared to the first quarter of 2010 and increased \$48 million, or 26% compared to the fourth quarter of 2010. The \$12 million increase in net revenue compared to the first quarter of 2010 was driven by a \$9 million increase in European derivatives net trading revenue on a 4% increase in average net revenue capture per contract on stable average daily volume ("ADV") (excluding Bclear) and a \$4 million increase in net U.S. equity options trading net revenue driven by a 19% increase in ADV, partially offset by a 9% decline in average net capture per contract. The \$48 million increase in net revenue compared to the fourth quarter of 2010 was driven by strong increases in derivatives trading volumes, both in Europe and the U.S. European derivatives trading volumes increased 34% (excluding Bclear) with the average net revenue capture per contract increasing 3% and U.S. equity options trading volumes increased 19% with the average net revenue capture per contract decreasing 2%.
Cash Trading and Listings net revenue of \$328 million in the first quarter of 2011 increased \$16 million, or 5% compared to the first quarter of 2010 and increased \$18 million, or 6% compared to the fourth quarter of 2010. The \$16 million increase in net revenue compared to the first quarter of 2010 was primarily driven by a 32% increase in European cash ADV, a 15% increase in the U.S. cash average net revenue per 100 shares handled and higher listing revenue. The \$18 million increase in net revenue compared to the fourth quarter of 2010 was primarily driven by a 29% increase in European cash ADV, partially offset by lower average net revenue per transaction on higher volume and a 3% increase in U.S. cash ADV accompanied by a 14% increase in the average net revenue per 100 shares handled.
Information Services and Technology Solutions revenue was \$116 million in the first quarter of 2011, an increase of \$6 million, or 5% compared to the first quarter of 2010 and a \$2 million, or 2% increase compared to the fourth quarter of 2010. The \$6 million increase in revenue compared to the first quarter of 2010 was primarily driven by an increase in SFTI fees resulting from expansion in the U.S. as well as Europe. The first quarter is a seasonally slow period for technology sales and as the pipeline of technology sales continues to build, NYSE Technologies is on-track to achieve total segment revenue
growth of greater than 15% in 2011 compared to 2010. The \$2 million increase compared to the fourth quarter of 2010 was primarily driven by an increase in SFTI and European market data fees.
The accompanying tables include information integral to assessing the Company"s financial performance.
A live video webcast of the 2011 Annual Meeting of Stockholders will be available directly through www.virtualshareholdermeeting.com/nyx or through the Investor Relations section of NYSE Euronext"s website, http://www.nyseeuronext.com/ir. Those wishing to listen to the live 2011 Annual Meeting of Stockholders via telephone should dial-in at least ten minutes before the call begins. A replay of the video webcast will be available at approximately 10:00 a.m. (NY/EDT) directly through www.virtualshareholdermeeting.com/nyx or through the Investor Relations section of NYSE Euronext"s website, http://www.nyseeuronext.com/ir.
United States: 800.860.2442 International: 412.858.4600
To supplement NYSE Euronext"s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure, calculated and presented in accordance with GAAP. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results, but are provided to (i) present the effects of certain merger expenses, exit costs and other special items, and (ii) improve overall understanding of NYSE Euronext"s current financial performance and its prospects for the future. Specifically, NYSE Euronext believes the non-GAAP financial results provide useful information to both management and investors regarding certain additional financial and business trends relating to financial condition and operating results. In addition, management uses these measures for reviewing financial results and evaluating financial performance. The non-GAAP adjustments for all periods presented are based upon information and assumptions available as of the date of this release.
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.
NYSE Euronext is party to a proposed business combination transaction with Deutsche Boerse AG. In connection with the proposed business combination transaction, Alpha Beta Netherlands Holding N.V. ("Holding"), a newly formed holding company, has filed a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission ("SEC") that includes (1) a draft proxy statement of NYSE Euronext that will also constitute a prospectus for Holding and (2) a draft offering prospectus of Holding to be used in connection with Holding"s offer to acquire Deutsche Boerse AG shares held by U.S. holders. When finalized, NYSE Euronext will mail the proxy statement/prospectus to its stockholders in connection with the vote to approve the merger of NYSE Euronext and a wholly owned subsidiary of Holding, and Holding will mail the offering prospectus to Deutsche Boerse AG shareholders in the United States in connection with Holding"s offer to acquire all of the outstanding shares of Deutsche Boerse AG. NYSE Euronext and Deutsche Boerse AG also expect that Holding will file an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) ("BaFin").
Investors and security holders are urged to read the proxy statement/prospectus and the offer document regarding the proposed business combination transaction if and when they become available because they will contain important information. You may obtain a free copy of the proxy statement/prospectus (if and when it becomes available) and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC"s Web site at www.sec.gov. The proxy statement/prospectus (if and when it becomes available) and other documents relating thereto may also be obtained for free by accessing NYSE Euronext"s Web site at www.nyse.com and Deutsche Boerse AG"s Web site at www.deutsche-boerse.com. The offer document will be made available at Holding"s Web site at www.global-exchange-operator.com following clearance by the BaFin.
This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer will be disclosed in the offer document after the publication has been approved by the BaFin and in documents that will be filed with the SEC. Holding reserves the right to deviate in the final terms of the public offer from the basic information described herein. Investors and holders of NYSE Euronext shares and Deutsche Boerse AG shares are strongly encouraged to read the offer document and all documents in connection with the public offer as soon as they are published, since they will contain important information.
No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, the public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.
This announcement and related materials do not constitute in France an offer for ordinary shares in Alpha Beta Netherlands Holding N.V. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.
NYSE Euronext, Deutsche Boerse AG, Holding and their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from NYSE Euronext stockholders in respect of the proposed business combination transaction. Additional information regarding the interests of such potential participants will be included in the proxy statement/prospectus and the other relevant documents filed with the SEC if and when they become available.
This document includes forward-looking statements about NYSE Euronext, Deutsche Boerse AG, Holding, the enlarged group and other persons, which may include statements about the proposed business combination, the likelihood that such transaction could be consummated, the effects of any transaction on the businesses of NYSE Euronext or Deutsche Boerse AG, and other statements that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and actual results of operations, financial condition and liquidity, and the development of the industries in which NYSE Euronext and Deutsche Boerse AG operate may differ materially from those made in or suggested by the forward-looking statements contained in this document. Any forward-looking statements speak only as at the date of this document. Except as required by applicable law, none of NYSE Euronext, Deutsche Boerse AG or Holding undertakes any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.
+31.20.550.4488 (Amsterdam) +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon) +44.20.7379.2789 (London) +1.212.656.2140 (New York) +33.1.49.27.11.33 (Paris)
+1.212.656.5700 (New York)
Condensed consolidated statements of income (unaudited)
(in millions, except per share data)
| March 31, 2011 | December 31, 2010 | March 31, 2010 | |
|---|---|---|---|
| Revenues | |||
| Transaction and clearing fees | \$ 815 |
\$ 713 |
\$ 762 |
| Market data | 96 | 95 | 91 |
| Listing | 109 | 107 | 105 |
| Technology services | 82 | 82 | 79 |
| Other revenues | 46 | 48 | 46 |
| Total revenues | 1,148 | 1,045 | 1,083 |
| Transaction-based expenses: | |||
| Section 31 fees | 89 | 76 | 63 |
| Liquidity payments, routing and clearing | 380 | 356 | 375 |
| Total revenues, less transaction-based expenses | 679 | 613 | 645 |
| Other operating expenses | |||
| Compensation | 161 | 134 | 172 |
| Depreciation and amortization | 70 | 80 | 66 |
| Systems and communications | 52 | 55 | 52 |
| Professional services | 69 | 82 | 58 |
| Selling, general and administrative | 63 | 74 | 79 |
| Merger expenses and exit costs | 21 | 18 | 13 |
| Total other operating expenses | 436 | 443 | 440 |
| Operating income | 243 | 170 | 205 |
| Net interest and investment income (loss) | (29) | (30) | (27) |
| Loss from associates | (1) | (2) | (2) |
| Other income (loss) | - | 2 | (3) |
| Income before income taxes | 213 | 140 | 173 |
| Income tax provision | (62) | (9) | (48) |
| Net income | 151 | 131 | 125 |
| Net loss attributable to noncontrolling interest | 4 | 4 | 5 |
| Net income attributable to NYSE Euronext | \$ 155 |
\$ 135 |
\$ 130 |
| Basic earnings per share attributable to NYSE Euronext | \$ 0.59 |
\$ 0.52 |
\$ 0.50 |
| Diluted earnings per share attributable to NYSE Euronext | \$ 0.59 |
\$ 0.51 |
\$ 0.50 |
| Basic weighted average shares outstanding | 261 | 261 | 260 |
| Diluted weighted average shares outstanding | 262 | 262 | 261 |
our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future. We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of
| Three months ended, | |||||
|---|---|---|---|---|---|
| Non-GAAP Reconciliation | March 31, 2011 | December 31, 2010 | March 31, 2010 | ||
| Income (loss) before income taxes - GAAP | \$ 213 |
\$ 140 |
\$ | 173 | |
| Excluding: | |||||
| Merger expenses and exit costs | 21 | 18 | 13 | ||
| Income before income taxes - as adjusted | 234 | 158 | 186 | ||
| Income tax provision | (61) | (42) | (51) | ||
| Net income - as adjusted | 173 | 116 | 135 | ||
| Net loss (income) attributable to noncontrolling interest | 4 | 4 | 5 | ||
| Net income attributable to NYSE Euronext - as adjusted | \$ 177 |
\$ 120 |
\$ | 140 | |
| Diluted earnings per share attributable to NYSE Euronext | \$ 0.68 |
\$ 0.46 |
\$ | 0.54 |
| Three months ended | March 31, 2011 | Three months ended March 31, 2010 |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Information | Information | |||||||||||||||||
| Services and | Corporate | Cash | Services and | |||||||||||||||
| Cash Trading | Technology | and | Trading and | Technology | Corporate and | |||||||||||||
| Derivatives | and Listings | Solutions | Eliminations | Consolidated | Derivatives | Listings | Solutions | Eliminations | Consolidated | |||||||||
| Revenues | ||||||||||||||||||
| Transaction and clearing fees | \$ | 286 | \$ | 529 | \$ | - | \$ - |
\$ 815 |
\$ | 278 | \$ | 484 | \$ | - | \$ - |
\$ | 762 | |
| Market data | 12 | 50 | 34 | - | 96 | 12 | 48 | 31 | - | 91 | ||||||||
| Listing | - | 109 | - | - | 109 | - | 105 | - | - | 105 | ||||||||
| Technology services | - | - | 82 | - | 82 | - | - | 79 | - | 79 | ||||||||
| Other revenues | 9 | 38 | - | (1) | 46 | 8 | 39 | - | (1) | 46 | ||||||||
| Total revenues | 307 | 726 | 116 | (1) | 1,148 | 298 | 676 | 110 | (1) | 1,083 | ||||||||
| Transaction-based expenses: | ||||||||||||||||||
| Section 31 fees | - | 89 | - | - | 89 | - | 63 | - | - | 63 | ||||||||
| Liquidity payments, routing and clearing | 71 | 309 | - | - | 380 | 74 | 301 | - | - | 375 | ||||||||
| Total revenues, less transaction-based expenses | 236 | 328 | 116 | (1) | 679 | 224 | 312 | 110 | (1) | 645 | ||||||||
| Depreciation and amortization | [a] | 15 | 46 | 9 | - | 70 | 15 | 43 | 8 | - | 66 | |||||||
| Merger expenses and exit costs (M&E) | [b] | 1 | 3 | 1 | 16 | 21 | 3 | 7 | 2 | 1 | 13 | |||||||
| Other operating expenses | 75 | 157 | 79 | 34 | 345 | 79 | 163 | 85 | 34 | 361 | ||||||||
| Operating income - GAAP | [c] | \$ | 145 | \$ | 122 | \$ | 27 | \$ (51) |
\$ 243 |
\$ | 127 | \$ | 99 | \$ | 15 | \$ (36) |
\$ | 205 |
| Operating income excluding M&E | [c] + [b] | \$ | 146 | \$ | 125 | \$ | 28 | \$ (35) |
\$ 264 |
\$ | 130 | \$ | 106 | \$ | 17 | \$ (35) |
\$ | 218 |
| Adjusted EBITDA | [c] + [a] + [b] \$ | 161 | \$ | 171 | \$ | 37 | \$ (35) |
\$ 334 |
\$ | 145 | \$ | 149 | \$ | 25 | \$ (35) |
\$ | 284 | |
| Operating margin excluding M&E | 62% | 38% | 24% | N/M | 39% | 58% | 34% | 15% | N/M | 34% | ||||||||
| Adjusted EBITDA margin | 68% | 52% | 32% | N/M | 49% | 65% | 48% | 23% | N/M | 44% |
N/M = Not meaningful our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future. We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of
| Fixed operating expenses for the three months ended March 31, 2011 - GAAP | \$ 436 |
|
|---|---|---|
| Less: | ||
| Merger expenses and exit costs | (21) | |
| \$ 415 |
||
| Excluding the impact of: | ||
| Currency translation | (2) | |
| Acquisitions and dispositions, net | (4) * | |
| Fixed operating expenses for the three months ended March 31, 2011 - as adjusted | \$ 409 |
[a] |
| Fixed operating expenses for the three months ended March 31, 2010 - GAAP | \$ 440 |
|
| Less: | ||
| Merger expenses and exit costs | (13) | |
| \$ 427 |
[b] | |
| Variance (\$) | \$ (18) |
[a] - [b] = [c] |
| Variance (%) | -4% | [c] / [b] |
* Includes the contribution of APX and Corporate Board Member.
our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future. We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of
| March 31, | December | |
|---|---|---|
| 2011 | 31, 2010 | |
| Assets | ||
| Current assets: | ||
| Cash, cash equivalents, and short term financial investments | \$ 351 |
\$ 379 |
| Accounts receivable, net | 602 | 526 |
| Deferred income taxes | 77 | 120 |
| Other current assets | 203 | 149 |
| Total current assets | 1,233 | 1,174 |
| Property and equipment, net | 1,021 | 1,021 |
| Goodwill | 4,196 | 4,050 |
| Other intangible assets, net | 6,083 | 5,837 |
| Deferred income taxes | 611 | 633 |
| Other assets | 649 | 663 |
| Total assets | \$ 13,793 |
\$ 13,378 |
| Liabilities and equity | ||
| Accounts payable and accrued expenses | \$ 749 |
\$ 910 |
| Deferred revenue | 428 | 176 |
| Short term debt | 201 | 366 |
| Deferred income taxes | 3 | 2 |
| Total current liabilities | 1,381 | 1,454 |
| Long term debt | 2,156 | 2,074 |
| Deferred income taxes | 2,049 | 2,007 |
| Accrued employee benefits | 453 | 499 |
| Deferred revenue | 371 | 366 |
| Other liabilities | 106 | 134 |
| Total liabilities | 6,516 | 6,534 |
| Equity | 7,277 | 6,844 |
| Total liabilities and equity | \$ 13,793 |
\$ 13,378 |
| NYSE Euronext Selected Statistical Data: Volume Summary |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Average Daily Volume % ∆ 1Q11 |
% ∆ 1Q11 | Total Volume % ∆ 1Q11 |
% ∆ 1Q11 | |||||||
| (Unaudited) | 1Q11 | 4Q10 | vs. 4Q10 | 1Q10 | vs. 1Q10 | 1Q11 | 4Q10 | vs. 4Q10 | 1Q10 | vs. 1Q10 |
| Number of Trading Days - European Markets Number of Trading Days - U.S. Markets |
64 62 |
66 64 |
63 61 |
64 62 |
66 64 |
63 61 |
||||
| European Derivatives Products (contracts in thousands) | 4,633 3,737 | 24.0% 4,851 | -4.5% | 296,529 | 246,658 | 20.2% 305,606 | -3.0% | |||
| of which Bclear Avg. Net Rate Per Contract (ex. Bclear) |
771 | 861 \$ 0.692 \$ 0.674 |
-10.5% | 972 2.7% \$ 0.663 |
-20.7% 4.4% |
49,335 \$ 0.692 |
56,831 \$ 0.674 |
-13.2% 2.7% |
61,234 \$ 0.663 |
-19.4% 4.4% |
| Avg. Net Rate Per Contract (ex. Bclear) - Currency Neutral | \$ 0.692 \$ 0.684 | 1.2% \$ 0.681 | 1.6% | \$ 0.692 | \$ 0.684 | 1.2% | \$ 0.681 | 1.6% | ||
| Total Interest Rate Products1 | 2,700 1,817 | 48.6% 2,711 | -0.4% | 172,792 | 119,948 | 44.1% 170,820 | 1.2% | |||
| Short Term Interest Rate Products Medium and Long Term Interest Rate Products |
2,568 132 |
1,696 121 |
51.4% 8.6% |
2,594 117 |
-1.0% 12.0% |
164,371 8,421 |
111,949 8,000 |
46.8% 5.3% |
163,418 7,402 |
0.6% 13.8% |
| Total Equity Products2 | 1,845 1,851 | -0.3% 2,088 | -11.6% | 118,110 | 122,159 | -3.3% 131,513 | -10.2% | |||
| Individual Equity Products Futures |
1,266 575 |
1,341 702 |
-5.6% -18.2% |
1,466 726 |
-13.6% -20.8% |
81,011 36,777 |
88,517 46,353 |
-8.5% -20.7% |
92,343 45,712 |
-12.3% -19.5% |
| Options Equity Index Products |
691 580 |
639 510 |
8.2% 13.7% |
740 622 |
-6.6% -6.8% |
44,234 37,100 |
42,164 33,642 |
4.9% 10.3% |
46,631 39,170 |
-5.1% -5.3% |
| of which Bclear | 771 | 861 | -10.5% | 972 | -20.7% | 49,335 | 56,831 | -13.2% | 61,234 | -19.4% |
| Individual E quit y P roduc t s Futures |
690 569 |
780 699 |
-11.5% -18.5% |
851 725 |
-19.0% -21.4% |
44,152 36,437 |
51,473 46,108 |
-14.2% -21.0% |
53,634 45,653 |
-17.7% -20.2% |
| Options | 121 | 81 | 48.3% | 127 | -4.8% | 7,715 | 5,365 | 43.8% | 7,981 | -3.3% |
| Equity Index Products | 81 | 81 | -0.2% | 121 | -32.9% | 5,183 | 5,358 | -3.3% | 7,600 | -31.8% |
| Commodity Products | 88 | 69 | 27.4% | 52 | 70.5% | 5,627 | 4,551 | 23.6% | 3,273 | 71.9% |
| U.S. Derivatives Products - Equity Options 3 (contracts in thousands) | ||||||||||
| Options Contracts Avg. Net Rate Per Contract |
4,408 | 3,715 \$ 0.165 \$ 0.168 |
18.7% | 3,713 -1.8% \$ 0.181 |
18.7% -8.8% |
273,323 \$ 0.165 |
237,774 \$ 0.168 |
15.0% -1.8% |
226,490 \$ 0.181 |
20.7% -8.8% |
| Total Consolidated Options Contracts Share of Total Consolidated Options Contracts |
25.5% | 17,298 15131.76 24.6% |
14.3% | 13975 26.6% |
23.8% | 1,072,501 25.5% |
968,433 24.6% |
10.7% | 852,501 26.6% |
25.8% |
| NYSE Liffe U.S. | ||||||||||
| Futures and Futures Options Volume* | 21.7 | 14.9 | 45.8% | 20.8 | 4.5% | 1,347.3 | 956.7 | 40.8% | 1,267.7 | 6.3% |
| European Cash Products (trades in thousands) | 1,803 1,400 | 28.8% 1,369 | 31.7% | 115,377 | 92,390 | 24.9% | 86,224 | 33.8% | ||
| Avg. Net Revenue Per Transaction Avg. Net Revenue Per Transaction - Currency Neutral |
\$ 0.667 \$ 0.714 \$ 0.667 \$ 0.719 |
-6.6% \$ 0.800 -7.2% \$ 0.793 |
-16.6% -15.9% |
\$ 0.667 \$ 0.667 |
\$ 0.714 \$ 0.719 |
-6.6% -7.2% |
\$ 0.800 \$ 0.793 |
-16.6% -15.9% |
||
| Equities | 1,732 1,341 | 29.1% 1,313 | 31.9% | 110,841 | 88,522 | 25.2% | 82,696 | 34.0% | ||
| Exchange-Traded Funds Structured Products |
21 45 |
17 36 |
21.0% 24.7% |
16 34 |
28.5% 32.0% |
1,316 2,873 |
1,108 2,387 |
18.8% 20.4% |
1,012 2,115 |
30.1% 35.8% |
| Bonds | 5 6 |
-9.5% | 6 | -9.5% | 347 | 373 | -6.8% | 401 | -13.3% | |
| U.S. Cash Products (shares in millions) Avg. Net Fee Per 100 Shares Handled |
2,309 2,233 \$ 0.0370 \$ 0.0326 |
3.4% 2,541 13.5% \$ 0.0323 |
-9.1% 14.6% |
143,183 \$ 0.0370 |
142,924 \$ 0.0326 |
0.2% 154,993 13.5% \$ 0.0323 |
-7.6% 14.6% |
|||
| NYSE Listed (Tape A) Issues 4 | ||||||||||
| Handled Volume 5 | 1,668 | 1,621 | 2.9% | 1,824 | -8.6% | 103,397 | 103,764 | -0.4% | 111,249 | -7.1% |
| Matched Volume 6 Total NYSE Listed Consolidated Volume |
1,578 4,568 |
1,536 4,335 |
2.7% 5.4% |
1,692 4,866 |
-6.8% -6.1% |
97,806 283,211 |
98,325 277,427 |
-0.5% 2.1% |
103,195 296,818 |
-5.2% -4.6% |
| Share of Total Consolidated Volume | ||||||||||
| Handled Volume 5 | 36.5% | 37.4% | -2.4% | 37.5% | -1.0% | 36.5% | 37.4% | -2.4% | 37.5% | -1.0% |
| Matched Volume 6 | 34.5% | 35.4% | -2.5% | 34.8% | -0.3% | 34.5% | 35.4% | -2.5% | 34.8% | -0.3% |
| NYSE Arca & Amex (Tape B) Listed Issues | ||||||||||
| Handled Volume 5 Matched Volume 6 |
347 311 |
325 294 |
6.5% 5.5% |
381 337 |
-9.1% -7.9% |
21,491 19,270 |
20,825 18,847 |
3.2% 2.2% |
23,260 20,579 |
-7.6% -6.4% |
| Total NYSE Arca & Amex Listed Consolidated Volume | 1,351 | 1,221 | 10.7% | 1,470 | -8.1% | 83,751 | 78,122 | 7.2% | 89,652 | -6.6% |
| Share of Total NYSE Arca & NYSE Amex Listed Consolidated Volume Handled Volume 5 |
25.7% | 26.7% | -3.7% | 25.9% | -0.2% | 25.7% | 26.7% | -3.7% | 25.9% | -0.2% |
| Matched Volume 6 | 23.0% | 24.1% | -4.6% | 23.0% | 0.0% | 23.0% | 24.1% | -4.6% | 23.0% | 0.0% |
| Nasdaq Listed Issues (Tape C) | ||||||||||
| Handled Volume 5 Matched Volume 6 |
295 251 |
286 246 |
3.0% 2.2% |
336 275 |
-12.1% -8.5% |
18,295 15,572 |
18,335 15,735 |
-0.2% -1.0% |
20,484 16,750 |
-10.7% -7.0% |
| Total Nasdaq Listed Consolidated Volume | 2,051 | 1,893 | 8.4% | 2,339 | -12.3% | 127,166 | 121,123 | 5.0% | 142,682 | -10.9% |
| Share of Total Nasdaq Listed Consolidated Volume Handled Volume 5 |
14.4% | 15.1% | -4.6% | 14.4% | 0.0% | 14.4% | 15.1% | -4.6% | 14.4% | 0.0% |
| Matched Volume 6 | 12.2% | 13.0% | -6.2% | 11.7% | 0.5% | 12.2% | 13.0% | -6.2% | 11.7% | 0.5% |
| Exchange-Traded Funds 5,7 | ||||||||||
| Handled Volume 5 | 315 | 305 | 3.5% | 365 | -13.5% | 19,557 | 19,502 | 0.3% | 22,256 | -12.1% |
| Matched Volume 6 Total ETF Consolidated Volume |
283 1,245 |
276 1,157 |
2.4% 7.6% |
324 1,443 |
-12.7% -13.7% |
17,543 77,213 |
17,681 74,056 |
-0.8% 4.3% |
19,774 88,017 |
-11.3% -12.3% |
| Share of Total ETF Consolidated Volume | ||||||||||
| Handled Volume 5 Matched Volume 6 |
25.3% 22.7% |
26.3% 23.9% |
-3.8% -5.0% |
25.3% 22.5% |
0.0% 0.2% |
25.3% 22.7% |
26.3% 23.9% |
-3.8% -5.0% |
25.3% 22.5% |
0.0% 0.2% |
| 1 Data includes currency products. |
holesale derivatives. | |||||||||
| Includes all trading activities for Bclear, NYSE Liffe's clearing service for w | ||||||||||
| Includes trading in U.S. equity options contracts, not equity-index options. | ||||||||||
| Includes all volume executed in NYSE Group crossing sessions. Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external |
||||||||||
| market center. NYSE Arca routing includes odd-lots. Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. |
||||||||||
| 2 Includes Bclear trading 3 4 5 6 7 Data included in previously identified categories. * Includes trading from Interest rate futures over NYSE Liffe U.S. for 9 trading days in 1Q11. |
11 |
| NYSE Euronext | |||
|---|---|---|---|
| Selected Statistical Data: | |||
| Other Operating Statistics | |||
| Three Months Ended | |||
| March 31, | December | ||
| (Unaudited) | 2011 | 31, 2010 | March 31, 2010 |
| NYSE Euronext Listed Issuers | |||
| NYSE Listed Issuers | |||
| Issuers listed on U.S. Markets1 | 2,952 | 2,940 | 2,919 |
| Number of new issuer listings1 | 44 | 62 | 39 |
| Capital raised in connection with new listings (\$millions)2 | \$12,446 | \$21,303 | \$3,472 |
| Euronext Listed Issuers | |||
| Issuers listed on Euronext1 | 974 | 980 | 1,031 |
| Number of new issuer listings3 | 10 | 18 | 18 |
| Capital raised in connection with new listings (\$millions)2 | \$29 | \$31 | \$432 |
| NYSE Euronext Market Data | |||
| NYSE Market Data4 | |||
| Share of Tape A revenues (%) Share of Tape B revenues (%) |
47.6% 31.1% |
49.0% 32.1% |
44.4% 34.2% |
| Share of Tape C revenues (%) | 19.7% | 21.0% | 18.4% |
| Professional subscribers (Tape A) | 374,285 | 377,481 | 381,873 |
| Euronext Market Data | |||
| Number of terminals | 233,289 | 238,539 | 238,905 |
| NYSE Euronext Operating Expenses | |||
| NYSE Euronext employee headcount | |||
| NYSE Euronext headcount | 3,028 | 2,968 | 3,216 |
| NYSE Euronext Financial Statistics | |||
| NYSE Euronext foreign exchange rate | |||
| Average €/US\$ exchange rate Average £/US\$ exchange rate |
\$1.368 \$1.602 |
\$1.359 \$1.581 |
\$1.384 \$1.560 |
| 1 Figures for NYSE listed issuers include listed operating companies, special-purpose acquisition companies and closed-end funds listed on the NYSE and NYSE Amex and do not include NYSE Arca or structured products listed on the NYSE. There w exclusively listed on NYSE Arca as of March 31, 2011. There w Figures for new issuer listings include NYSE new listings (including new end funds listing on NYSE) and new ETP listings on NYSE Arca (NYSE Amex is excluded). Figures for Euronext present the operating companies w ere listed on Euronext and do not include NYSE Alternext, Free Market, closed-end funds, ETFs and structured product (w As of March 31, 2011, 158 companies w ere listed on NYSE Alternext, 270 on Free Market and 618 ETFs w |
ere 477 corporate structured products listed on the NYSE as of March 31, 2011. | ere listed on NextTrack. | ere 1,173 ETFs and 2 operating companies operating companies, special-purpose acquisition companies and closed arrants and certificates). |
| 2 Euronext figures show capital raised in millions of dollars by operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (w operating companies listed on NYSE and NYSE Arca and do not include closed-end funds, ETFs and structured products. |
arrants and certificates). NYSE figures show | capital raised in millions of dollars by | |
| 3 Euronext figures include operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (w arrants and certificates). |
|||
| 4 "Tape A" represents NYSE listed securities, "Tape B" represents NYSE Arca and NYSE Amex listed securities, and "Tape C" represents Nasdaq listed securities. Per Regulation NMS, as of April 1, 2007, share of revenues is derived through a formula based on 25% share of trading, 25% share of value traded, and 50% share of quoting, as reported to the consolidated tape. Prior to April 1, 2007, share of revenues for Tape A and B w derived based on number of trades reported to the consolidated tape, and share of revenue for Tape C w of trades and share of volume reported to the consolidated tape. The consolidated tape refers to the collection and dissemination of market data that multiple markets make available on a consolidated basis. Share figures exclude transactions reported to the FINRA/NYSE Trade Reporting Facility. 12 |
as as derived based on an average of share |
||
| Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.